Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 382 | 276 | 824 |
| Receivables | 59 | 14 | 23 |
| Other current assets | 0 | 23 | 0 |
| TOTAL | $450 | $319 | $867 |
| Non-Current Assets | |||
| PPE Net | 146 | 59 | 70 |
| Intangibles | 556 | 149 | 75 |
| TOTAL | $702 | $207 | $145 |
| Total Assets | $1,152 | $526 | $1,012 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 135 | 100 | 57 |
| TOTAL | $135 | $100 | $57 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $135 | $100 | $57 |
| Shareholders' Equity | |||
| Retained earnings | -2,292 | -1,282 | -680 |
| Other shareholders' equity | 0 | 63 | 22 |
| TOTAL | $1,017 | $427 | $955 |
| Total Liabilities And Equity | $1,152 | $526 | $1,012 |